Hormone Therapy
Prior testosterone use does not impact egg freezing outcomes for transgender men
DENVER — Exposure to testosterone therapy did not impact outcomes related to egg freezing for transgender men who sought fertility preservation treatment, researchers reported.
Making menopause mainstream: A conversation with Monica Christmas, MD, FACOG, MSCP
Interest in menopause and all things related to midlife women’s health continues to grow, and The Menopause Society is expanding to meet the demand.
Long-acting intrauterine contraceptive device may raise breast cancer risk
Using a levonorgestrel-releasing intrauterine system device to prevent pregnancy increased risk for breast cancer among women living in Denmark aged 15 to 49 years, according to a research letter published in JAMA.
Top in women’s health: Treating hypoactive sexual desire disorder; addressing PCOS needs
Many midlife women experience hypoactive sexual desire disorder, which can impact both relationships and mental health, but two FDA approved treatments are available, according to a speaker at the Annual Meeting of The Menopause Society.
Poor hot flash documentation in primary care setting leaves many midlife women untreated
Many postmenopausal women self-reported moderate or higher vasomotor symptoms in the primary care setting but remained untreated due to lack of electronic health record documentation, researchers reported.
Top in women's health: Dobbs impacts OB/GYN residents; mammograms may predict CVD risk
After the Supreme Court’s Dobbs decision led abortion clinics in Wisconsin to close, OB/GYN residents living in the state participated in an out-of-state training partnership to obtain abortion training.
Primary ovarian insufficiency more than doubles midlife multimorbidity risk
Women with premature ovarian insufficiency and early menopause have increased multimorbidity compared with women with menopause onset at an average age of 46 to 55 years, according to findings published in Fertility and Sterility.
Menopausal hormone therapy use fell 82% since 1999, as ‘negative perceptions’ persist
Hormone therapy use markedly declined among postmenopausal women of all ages, races and ethnicities in the U.S. during the past 2 decades, according to findings published in JAMA Health Forum.
Hormone therapy use among menopausal women continues to decline, despite proven safety
CHICAGO — Hormone therapy use among menopausal women has fallen to just 1.8% as of 2023, data show, despite evidence and clinical guidance suggesting HT is safe and effective for most women for bothersome menopausal symptoms.
VIDEO: ‘Less than 1%’ of federal funding goes to menopause research, prompting new program
CHICAGO — In this Healio video exclusive, Susan D. Reed, MD, MPH, MS, past president of The Menopause Society, highlights a new pilot program created to improve funding for research in menopause health, with up to four awards of $25,000 each.